Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice
Author(s) -
Yusuke Shono,
Melissa D. Docampo,
Jonathan U. Peled,
Suelen Martins Perobelli,
Enrico Velardi,
Jennifer J. Tsai,
Ann E. Slingerland,
Odette M. Smith,
Lauren Young,
Jyotsna Gupta,
Sophia R. Lieberman,
Hillary Jay,
Katya Ahr,
Kori A. Porosnicu Rodriguez,
Ke Xu,
Marco Calarfiore,
Hendrik Poeck,
Silvia Caballero,
Sean M. Devlin,
Franck Rapaport,
Jarrod A. Dudakov,
Alan M. Hanash,
Boglarka Gyurkocza,
Gëorge F. Murphy,
Camilla Borges Ferreira Gomes,
Chen Liu,
Eli L. Moss,
Shan B. Falconer,
Ami S. Bhatt,
Ying Taur,
Eric G. Pamer,
Marcel R.M. van den Brink,
Robert R. Jenq
Publication year - 2016
Publication title -
science translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.819
H-Index - 216
eISSN - 1946-6242
pISSN - 1946-6234
DOI - 10.1126/scitranslmed.aaf2311
Subject(s) - hematopoietic stem cell transplantation , broad spectrum , stem cell , antibiotics , haematopoiesis , medicine , transplantation , immunology , graft versus host disease , disease , hematopoietic stem cell , neutropenia , hematopoietic cell , biology , chemotherapy , microbiology and biotechnology , chemistry , combinatorial chemistry , genetics
Treating neutropenic fever with broad-spectrum antibiotics after allogeneic hematopoietic stem cell transplant is associated with an increase in graft-versus-host disease in mice and humans.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom